Woodline Partners’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3M | Buy |
2,572,162
+1,735,148
| +207% | +$6.98M | 0.05% | 424 |
|
|
2025
Q1 | $2.9M | Sell |
837,014
-21,677
| -3% | -$75.2K | 0.02% | 610 |
|
|
2024
Q4 | $5.65M | Buy |
858,691
+6,730
| +0.8% | +$44.3K | 0.04% | 461 |
|
|
2024
Q3 | $7.7M | Buy |
851,961
+27,887
| +3% | +$252K | 0.06% | 334 |
|
|
2024
Q2 | $13.2M | Buy |
824,074
+812,023
| +6,738% | +$13M | 0.13% | 217 |
|
|
2024
Q1 | $189K | Buy |
+12,051
| New | +$189K | ﹤0.01% | 514 |
|